As of April 19, 2025, Seres Therapeutics (MCRB) has a market cap of $64.513 million USD. According to our data, Seres Therapeutics is ranked No.7895 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $64.51 M |
-54.53%
|
Dec 31, 2024 | $0.14 B |
-40.64%
|
Dec 29, 2023 | $0.24 B |
-75.00%
|
Dec 30, 2022 | $0.96 B |
-32.77%
|
Dec 31, 2021 | $1.42 B |
-66.00%
|
Dec 31, 2020 | $4.18 B |
610.14%
|
Dec 31, 2019 | $0.59 B |
-23.67%
|
Dec 31, 2018 | $0.77 B |
-55.42%
|
Dec 29, 2017 | $1.73 B |
2.42%
|
Dec 30, 2016 | $1.69 B |
-71.79%
|
Dec 31, 2015 | $5.99 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Synlogic
SYBX
|
$12.40 M |
0.000 M
|
![]() USA
|
![]() Entera Bio
ENTX
|
$81.30 M |
-0.000 M
|
![]() Israel
|
Market Cap | = | MCRB Stock Price | * | MCRB Shares Outstanding |
= | $0.37 | * | 0.17 B | |
= | $64.51 M |